[1]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
|
[2]
|
Causeret, F., Sumia, I. and Pierani, A. (2015) Kremen1 and Dickkopf1 Control Cell Survival in a Wnt-Independent Manner. Cell Death & Differentiation, 23, 323-332. https://doi.org/10.1038/cdd.2015.100
|
[3]
|
Gottesman, M.M., Lavi, O., Hall, M.D. and Gillet, J. (2016) Toward a Better Understanding of the Complexity of Cancer Drug Resistance. Annual Review of Pharmacology and Toxicology, 56, 85-102. https://doi.org/10.1146/annurev-pharmtox-010715-103111
|
[4]
|
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K. and Kovanen, P.T. (2019) Inflammation and Its Resolution in Atherosclerosis: Mediators and Therapeutic Opportunities. Nature Reviews Cardiology, 16, 389-406. https://doi.org/10.1038/s41569-019-0169-2
|
[5]
|
Kist, M. and Vucic, D. (2021) Cell Death Pathways: Intricate Connections and Disease Implications. The EMBO Journal, 40, e106700. https://doi.org/10.15252/embj.2020106700
|
[6]
|
Liu, Y., Bhattarai, P., Dai, Z. and Chen, X. (2019) Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer. Chemical Society Reviews, 48, 2053-2108. https://doi.org/10.1039/c8cs00618k
|
[7]
|
Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., et al. (2018) Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25, 486-541. https://doi.org/10.1038/s41418-017-0012-4
|
[8]
|
Tang, D., Kang, R., Berghe, T.V., Vandenabeele, P. and Kroemer, G. (2019) The Molecular Machinery of Regulated Cell Death. Cell Research, 29, 347-364. https://doi.org/10.1038/s41422-019-0164-5
|
[9]
|
Shan, B., Pan, H., Najafov, A. and Yuan, J. (2018) Necroptosis in Development and Diseases. Genes & Development, 32, 327-340. https://doi.org/10.1101/gad.312561.118
|
[10]
|
Dhuriya, Y.K. and Sharma, D. (2018) Necroptosis: A Regulated Inflammatory Mode of Cell Death. Journal of Neuroinflammation, 15, Article No. 199. https://doi.org/10.1186/s12974-018-1235-0
|
[11]
|
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., et al. (2005) Chemical Inhibitor of Nonapoptotic Cell Death with Therapeutic Potential for Ischemic Brain Injury. Nature Chemical Biology, 1, 112-119. https://doi.org/10.1038/nchembio711
|
[12]
|
Degterev, A., Hitomi, J., Germscheid, M., Chen, I.L., Korkina, O., Teng, X., et al. (2008) Identification of RIP1 Kinase as a Specific Cellular Target of Necrostatins. Nature Chemical Biology, 4, 313-321. https://doi.org/10.1038/nchembio.83
|
[13]
|
Yuan, J., Amin, P. and Ofengeim, D. (2018) Necroptosis and RIPK1-Mediated Neuroinflammation in CNS Diseases. Nature Reviews Neuroscience, 20, 19-33. https://doi.org/10.1038/s41583-018-0093-1
|
[14]
|
Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., et al. (2014) RIP3, a Kinase Promoting Necroptotic Cell Death, Mediates Adverse Remodelling after Myocardial Infarction. Cardiovascular Research, 103, 206-216. https://doi.org/10.1093/cvr/cvu146
|
[15]
|
Oerlemans, M.I.F.J., Liu, J., Arslan, F., Ouden, K., Middelaar, B.J., Doevendans, P.A., et al. (2012) Inhibition of RIP1-Dependent Necrosis Prevents Adverse Cardiac Remodeling after Myocardial Ischemia-Reperfusion in vivo. Basic Research in Cardiology, 107, 270. https://doi.org/10.1007/s00395-012-0270-8
|
[16]
|
Kung, J.E. and Jura, N. (2019) Prospects for Pharmacological Targeting of Pseudokinases. Nature Reviews Drug Discovery, 18, 501-526. https://doi.org/10.1038/s41573-019-0018-3
|
[17]
|
Kwok, A.J., Mentzer, A. and Knight, J.C. (2020) Host Genetics and Infectious Disease: New Tools, Insights and Translational Opportunities. Nature Reviews Genetics, 22, 137-153. https://doi.org/10.1038/s41576-020-00297-6
|
[18]
|
Harris, P.A., King, B.W., Bandyopadhyay, D., Berger, S.B., Campobasso, N., Capriotti, C.A., et al. (2016) Dna-Encoded Library Screening Identifies Benzo[b][1,4]Oxazepin-4-Ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. Journal of Medicinal Chemistry, 59, 2163-2178. https://doi.org/10.1021/acs.jmedchem.5b01898
|
[19]
|
Harris, P.A., Berger, S.B., Jeong, J.U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., et al. (2017) Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry, 60, 1247-1261. https://doi.org/10.1021/acs.jmedchem.6b01751
|
[20]
|
Frank, D. and Vince, J.E. (2018) Pyroptosis versus Necroptosis: Similarities, Differences, and Crosstalk. Cell Death & Differentiation, 26, 99-114. https://doi.org/10.1038/s41418-018-0212-6
|
[21]
|
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L.V., Louie, S., Dong, J., et al. (2011) Non-Canonical Inflammasome Activation Targets Caspase-11. Nature, 479, 117-121. https://doi.org/10.1038/nature10558
|
[22]
|
Martinon, F., Burns, K. and Tschopp, J. (2002) The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-β. Molecular Cell, 10, 417-426. https://doi.org/10.1016/s1097-2765(02)00599-3
|
[23]
|
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C. and Chen, X. (2021) Pyroptosis: Mechanisms and Diseases. Signal Transduction and Targeted Therapy, 6, Article No. 128. https://doi.org/10.1038/s41392-021-00507-5
|
[24]
|
Fearnhead, H.O., Vandenabeele, P. and Vanden Berghe, T. (2017) How Do We Fit Ferroptosis in the Family of Regulated Cell Death? Cell Death & Differentiation, 24, 1991-1998. https://doi.org/10.1038/cdd.2017.149
|
[25]
|
Jiang, X., Stockwell, B.R. and Conrad, M. (2021) Ferroptosis: Mechanisms, Biology and Role in Disease. Nature Reviews Molecular Cell Biology, 22, 266-282. https://doi.org/10.1038/s41580-020-00324-8
|
[26]
|
Conrad, M., Lorenz, S.M. and Proneth, B. (2021) Targeting Ferroptosis: New Hope for As-yet-Incurable Diseases. Trends in Molecular Medicine, 27, 113-122. https://doi.org/10.1016/j.molmed.2020.08.010
|
[27]
|
Lei, G., Zhuang, L. and Gan, B. (2022) Targeting Ferroptosis as a Vulnerability in Cancer. Nature Reviews Cancer, 22, 381-396. https://doi.org/10.1038/s41568-022-00459-0
|
[28]
|
Zhang, Y., Tan, H., Daniels, J.D., Zandkarimi, F., Liu, H., Brown, L.M., et al. (2019) Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. Cell Chemical Biology, 26, 623-633. https://doi.org/10.1016/j.chembiol.2019.01.008
|
[29]
|
Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., et al. (2022) Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins. Science, 375, 1254-1261. https://doi.org/10.1126/science.abf0529
|
[30]
|
Lichtmannegger, J., Leitzinger, C., Wimmer, R., Schmitt, S., Schulz, S., Kabiri, Y., et al. (2016) Methanobactin Reverses Acute Liver Failure in a Rat Model of Wilson Disease. Journal of Clinical Investigation, 126, 2721-2735. https://doi.org/10.1172/jci85226
|
[31]
|
Liu, X., Nie, L., Zhang, Y., Yan, Y., Wang, C., Colic, M., et al. (2023) Actin Cytoskeleton Vulnerability to Disulfide Stress Mediates Disulfidptosis. Nature Cell Biology, 25, 404-414. https://doi.org/10.1038/s41556-023-01091-2
|
[32]
|
Liu, X., Zhuang, L. and Gan, B. (2024) Disulfidptosis: Disulfide Stress-Induced Cell Death. Trends in Cell Biology, 34, 327-337. https://doi.org/10.1016/j.tcb.2023.07.009
|